TrialThe Journal of urology2024

Efficacy and Safety of TAS-303 in Female Patients With Stress Urinary Incontinence: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial.

Satoru Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.